InsidersTradesSigma
Follow the Amerise Biosciences stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €5.7m. The latest transaction was reported on 16 June 2026 (Acquisition). Among the most active insiders: Snehjeev Ventures Pvt Ltd & PACs. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Amerise Biosciences is a company focused on developing innovative biopharmaceutical solutions. It operates in the XBOM market.